Stay updated on Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.

Latest updates to the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedNew version entry added to the Study Record History: Revision: v3.6.5. This indicates a recent update to the record since the previous version (v3.6.4).SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe page history now shows a new revision label, updating from Revision: v3.6.3 to Revision: v3.6.4. This indicates a minor update to the page's record.SummaryDifference0.1%

- Check43 days agoChange DetectedTwo new sections, Contacts/Locations and Study Status, were added to the study history page on 2026-07-07, improving access to contact details and the current study status. A prior entry from 2026-06-22 was removed from the history.SummaryDifference0.3%

- Check50 days agoChange DetectedA new revision entry (v3.6.3) was added to the history, replacing the previous v3.6.2. This indicates an incremental update to the study record's documentation.SummaryDifference0.1%

- Check57 days agoChange DetectedA new version entry (38) is added to the record history, including updates to Study Status and Contacts/Locations and recorded as Revision: v3.6.2. The previous revision (v3.6.0) was removed.SummaryDifference0.4%

- Check71 days agoChange DetectedThe history adds a new note stating 'No longer looking for participants' and records the revision as v3.6.0. The previous revision tag v3.5.5 is removed from the history.SummaryDifference0.3%

Stay in the know with updates to Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.